Anti-SARS-CoV-2 Small Molecule Targeting of Oxysterol-Binding Protein (OSBP) Activates Cellular Antiviral Innate Immunity.
Saved in:
| Title: | Anti-SARS-CoV-2 Small Molecule Targeting of Oxysterol-Binding Protein (OSBP) Activates Cellular Antiviral Innate Immunity. |
|---|---|
| Authors: | Subramaniyan B; Department of Medicine, Section of Pulmonary, Critical Care & Sleep Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma 73104, United States., Falcon EC; Department of Pharmaceutical Sciences, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma 73117, United States., Moore AR; Department of Medicine, Section of Pulmonary, Critical Care & Sleep Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma 73104, United States., Larabee JL; Department of Microbiology and Immunology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma 73104, United States., Nimmo SL; Department of Pharmaceutical Sciences, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma 73117, United States., Berrios-Rivera JL; Department of Pharmaceutical Sciences, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma 73117, United States., Reddig WJ; Department of Biochemistry and Microbiology, Oklahoma State University Center for Health Sciences, Tulsa, Oklahoma 74107, United States., Blewett EL; Department of Biochemistry and Microbiology, Oklahoma State University Center for Health Sciences, Tulsa, Oklahoma 74107, United States., Papin JF; Department of Pathology, Division of Comparative Medicine, University of Oklahoma Health Sciences Center, Oklahoma 73104, United States., Walters MS; Department of Medicine, Section of Pulmonary, Critical Care & Sleep Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma 73104, United States., Burgett AWG; Department of Pharmaceutical Sciences, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma 73117, United States.; Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma 73104, United States. |
| Source: | ACS infectious diseases [ACS Infect Dis] 2025 May 09; Vol. 11 (5), pp. 1064-1077. Date of Electronic Publication: 2025 Apr 21. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: ACS Publications Country of Publication: United States NLM ID: 101654580 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2373-8227 (Electronic) Linking ISSN: 23738227 NLM ISO Abbreviation: ACS Infect Dis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40255103 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Anti-SARS-CoV-2 Small Molecule Targeting of Oxysterol-Binding Protein (OSBP) Activates Cellular Antiviral Innate Immunity. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Subramaniyan+B%22">Subramaniyan B</searchLink>; Department of Medicine, Section of Pulmonary, Critical Care & Sleep Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma 73104, United States.<br /><searchLink fieldCode="AU" term="%22Falcon+EC%22">Falcon EC</searchLink>; Department of Pharmaceutical Sciences, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma 73117, United States.<br /><searchLink fieldCode="AU" term="%22Moore+AR%22">Moore AR</searchLink>; Department of Medicine, Section of Pulmonary, Critical Care & Sleep Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma 73104, United States.<br /><searchLink fieldCode="AU" term="%22Larabee+JL%22">Larabee JL</searchLink>; Department of Microbiology and Immunology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma 73104, United States.<br /><searchLink fieldCode="AU" term="%22Nimmo+SL%22">Nimmo SL</searchLink>; Department of Pharmaceutical Sciences, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma 73117, United States.<br /><searchLink fieldCode="AU" term="%22Berrios-Rivera+JL%22">Berrios-Rivera JL</searchLink>; Department of Pharmaceutical Sciences, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma 73117, United States.<br /><searchLink fieldCode="AU" term="%22Reddig+WJ%22">Reddig WJ</searchLink>; Department of Biochemistry and Microbiology, Oklahoma State University Center for Health Sciences, Tulsa, Oklahoma 74107, United States.<br /><searchLink fieldCode="AU" term="%22Blewett+EL%22">Blewett EL</searchLink>; Department of Biochemistry and Microbiology, Oklahoma State University Center for Health Sciences, Tulsa, Oklahoma 74107, United States.<br /><searchLink fieldCode="AU" term="%22Papin+JF%22">Papin JF</searchLink>; Department of Pathology, Division of Comparative Medicine, University of Oklahoma Health Sciences Center, Oklahoma 73104, United States.<br /><searchLink fieldCode="AU" term="%22Walters+MS%22">Walters MS</searchLink>; Department of Medicine, Section of Pulmonary, Critical Care & Sleep Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma 73104, United States.<br /><searchLink fieldCode="AU" term="%22Burgett+AWG%22">Burgett AWG</searchLink>; Department of Pharmaceutical Sciences, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma 73117, United States.; Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma 73104, United States. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101654580%22">ACS infectious diseases</searchLink> [ACS Infect Dis] 2025 May 09; Vol. 11 (5), pp. 1064-1077. <i>Date of Electronic Publication: </i>2025 Apr 21. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22ACS+Publications%22">ACS Publications </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101654580 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2373-8227 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2223738227%22">23738227 </searchLink><i>NLM ISO Abbreviation: </i>ACS Infect Dis <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40255103 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1021/acsinfecdis.4c00631 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1064 Titles: – TitleFull: Anti-SARS-CoV-2 Small Molecule Targeting of Oxysterol-Binding Protein (OSBP) Activates Cellular Antiviral Innate Immunity. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Subramaniyan B – PersonEntity: Name: NameFull: Falcon EC – PersonEntity: Name: NameFull: Moore AR – PersonEntity: Name: NameFull: Larabee JL – PersonEntity: Name: NameFull: Nimmo SL – PersonEntity: Name: NameFull: Berrios-Rivera JL – PersonEntity: Name: NameFull: Reddig WJ – PersonEntity: Name: NameFull: Blewett EL – PersonEntity: Name: NameFull: Papin JF – PersonEntity: Name: NameFull: Walters MS – PersonEntity: Name: NameFull: Burgett AWG IsPartOfRelationships: – BibEntity: Dates: – D: 09 M: 05 Text: 2025 May 09 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 2373-8227 Numbering: – Type: volume Value: 11 – Type: issue Value: 5 Titles: – TitleFull: ACS infectious diseases Type: main |
| ResultId | 1 |